Mitochondrial components

The target refers to the intracellular and mitochondrial components of malignant T-cells, which are selectively targeted in photodynamic therapy (PDT) for conditions such as cutaneous T-cell lymphoma (CTCL). Photosensitizing agents, such as hypericin (SGX301) or 5-aminolevulinic acid (5-ALA), preferentially accumulate within the mitochondria of neoplastic T-cells due to their high metabolic activity and altered membrane permeability. Upon exposure to specific wavelengths of visible light, these agents undergo a photochemical reaction that generates reactive oxygen species (ROS), primarily singlet oxygen. This localized oxidative stress causes irreversible damage to mitochondrial membranes, enzymes, and the electron transport chain, leading to the release of pro-apoptotic factors like cytochrome c. This process triggers the intrinsic apoptotic pathway, resulting in the selective destruction of malignant T-cells while sparing surrounding healthy tissue. This therapeutic strategy is particularly effective for treating skin-directed lesions in CTCL and is being explored for other T-cell malignancies.

Other names

MitochondriaMitochondrial membraneIntracellular organellesMitochondrial respiratory chain

Photosensitizing agents preferentially accumulate in the mitochondria of malignant T-cells; upon activation by specific wavelengths of light, they generate reactive oxygen species (ROS), such as singlet oxygen, which cause oxidative damage to mitochondrial membranes and trigger the intrinsic apoptotic pathway.